CSPC Pharmaceutical Group Ltd. (CHJTF)
1.11
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 12.72B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -9.60% |
| Valuation | |
| PE Ratio | 11.80 |
| PE Ratio (Forward) | |
| PS Ratio | 2.824 |
| Price to Book Value | 9.895 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.0229 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 69.66% |
Profile
| CSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. It operates through the following business segments: Finished Drugs, Bulk Products, and Functional Food and Others. The Finished Drugs segment manages research and development, manufacture and sale of pharmaceutical products and license fee income. The Bulk Products offers manufacturing and sale of vitamin C, and antibiotic products in bulk powder form. The Functional Food and Others segment refers to manufacturing and sale of functional food products, provision of healthcare services, and others. The company was founded on August 21, 1997 and is headquartered in Shijiazhuang, China. |
| URL | http://www.cspc.com.hk |
| Investor Relations URL | N/A |
| HQ State/Province | Hebei |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap Core |
| Next Earnings Release | Nov. 19, 2026 (est.) |
| Last Earnings Release | Aug. 20, 2026 |
| Next Ex-Dividend Date | Oct. 22, 2026 |
| Last Ex-Dividend Date | Jun. 26, 2026 |
Profile
| CSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. It operates through the following business segments: Finished Drugs, Bulk Products, and Functional Food and Others. The Finished Drugs segment manages research and development, manufacture and sale of pharmaceutical products and license fee income. The Bulk Products offers manufacturing and sale of vitamin C, and antibiotic products in bulk powder form. The Functional Food and Others segment refers to manufacturing and sale of functional food products, provision of healthcare services, and others. The company was founded on August 21, 1997 and is headquartered in Shijiazhuang, China. |
| URL | http://www.cspc.com.hk |
| Investor Relations URL | N/A |
| HQ State/Province | Hebei |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap Core |
| Next Earnings Release | Nov. 19, 2026 (est.) |
| Last Earnings Release | Aug. 20, 2026 |
| Next Ex-Dividend Date | Oct. 22, 2026 |
| Last Ex-Dividend Date | Jun. 26, 2026 |